Paratek Pharmaceuticals Opens Philadelphia Office
News Jun 19, 2015
Paratek Pharmaceuticals, Inc. has opened a new Philadelphia office. The new office is located in King of Prussia, Pennsylvania.
"With two important antibiotic products in development, we have been growing our team rapidly. Our presence in Philadelphia enables us to attract world-class talent from the area's biopharmaceutical industry," said Evan Loh, President and Chief Medical Officer, Paratek. "This has already helped us identify and recruit key talent and will be critical as we continue to grow going forward."
Paratek, which is headquartered in Boston, opened its Philadelphia-area office in King of Prussia. The company currently employs 11 people in the Philadelphia region and expects to add to its local headcount over the next year as it advances its lead clinical development product candidate, omadacycline.
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
WuXi Biologics to Invest in Biologics Manufacturing Facility in SingaporeNews
WuXi Biologics' first overseas site in Asia.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018